United Kingdom · Series D startup
Funding summaryUpdated 26 Oct 2026
$148Mraised across 3 rounds since 2016, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
RA Capital Management
Sofinnova Partners
Janus Henderson Investors
RTW Investments LLC
EQT Life Sciences
AbbVieSource recorded
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
RA Capital ManagementSofinnova PartnersJanus Henderson InvestorsSV Life SciencesRTW Investments LLCEQT Life SciencesAbbVieMerck VenturesMissing a round, or an investor who was in one? Tell us.
These 2 firms list Artios Pharma as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Artios Pharma's investors include RA Capital Management, Sofinnova Partners, Janus Henderson Investors, SV Life Sciences and RTW Investments LLC, and 3 more on record.
Artios Pharma has raised $148M across 3 rounds since 2016.
Artios Pharma's most recent round was a Series D of $115M in Nov 2025.
Its most recent round, $115M in Nov 2025, is also its largest on record.
Artios Pharma's first round on record, in Sept 2016, was backed by SV Life Sciences and Merck Ventures.
Artios Pharma's latest named round is a Series D, in Nov 2025.
Artios Pharma is based in the United Kingdom.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United Kingdom · 
